Laos and China have agreed to enhance product quality, technology transfer, and market access for Lao farmers, while pledging to strengthen plant quarantine systems and cross-border disease prevention to ensure the safe and sustainable flow of Lao products to Yunnan Province.
Laos Expands Agricultural Exports to China Amid Stronger Bilateral Cooperation
Ban Ki-moon Praises LEPAS, JeryL Lee Joins the Experience — LEPAS Accelerates Its Expansion in Southeast Asia
WUHU, China, Oct. 27, 2025 /PRNewswire/ — During the 2025 Chery International User Summit, Mr. Ban Ki-moon, the 8th Secretary-General of the United Nations, visited Wuhu and toured the world’s first LEPAS Elegant Lifestyle House, viewing the LEPAS L8, LEPAS L6, and LEPAS L4 up close and sharing valuable insights on sustainability.
Ban Ki-moon Praises LEPAS, JeryL Lee Joins the Experience — LEPAS Accelerates Its Expansion in Southeast Asia
JeryL Lee, Malaysia’s rising pop star, also visited the LEPAS Elegant Lifestyle House to experience the brand’s “Elegant Life” philosophy firsthand. At the Chery International User Carnival, she appeared in the LEPAS L8, delivering captivating performance that strengthened LEPAS’s emotional connection with Southeast Asian consumers. Ybg. Mr. NG KAI SENG, Minister-Counsellor of the Embassy of Malaysia in China, also attended the summit, witnessing LEPAS’s remarkable “Elegant Driving” performance and its milestone in global expansion.
LEPAS made its international debut at the Indonesia International Auto Show (GIIAS) in Jakarta, officially launching its journey into the Southeast Asian market. With a full lineup of the three models, and a colorful booth, LEPAS’s exhibition drew widespread attention. The LEPAS L8, as the flagship model, embodies refined power and versatility; the LEPAS L6 represents smart sophistication, balancing intelligence and beauty; while the LEPAS L4, the new urban icon, captures youthful agility and style. Together, they vividly express LEPAS’s signature “Leopard Aesthetics”.
Positioned as the“Preferred Brand for Elegant Mobility Life, “LEPAS upholds its philosophy of“Drive Your Elegance,”to make every journey elegant. The brand name LEPAS carries three meanings: LE (Leopard) symbolizes the perfect fusion of speed, power, and grace, echoing the brand’s “Leopard Aesthetics”and technological mastery; LEAP reflects its global vision, transcending geographical and cultural boundaries; and PASSION conveys energy and inspiration, encouraging urban elites to explore refined, tech-driven lifestyles. The visits by Ban Ki-moon and JeryL Lee showcased how Chinese new energy brands are stepping onto the global stage. Guided by Chery Group’s global vision of “In somewhere, For somewhere, Be somewhere, “LEPAS will continue to deepen its presence in Southeast Asia, using LEPAS Elegant Technology and green mobility to empower every journey and light up the “Elegant Life” for users worldwide.
Raffles Medical Group Partners Gene Solutions to Expand Access to Global Cancer Clinical Trials
SINGAPORE, Oct. 27, 2025 /PRNewswire/ — Raffles Medical Group (the Group) and Gene Solutions have signed a Memorandum of Understanding (MOU) on 22 October 2025 to streamline patient recruitment for oncology clinical trials, marking a significant milestone in advancing precision medicine in Southeast Asia.
Under this partnership, the Group and Gene Solutions will collaborate to identify patients eligible for pharma-sponsored clinical trials. Patients undergoing Comprehensive Genomic Profiling (CGP) via Gene Solutions will be automatically screened for eligibility. The Group’s Clinical Trials Unit will collaborate closely with local oncologists to facilitate patient enrolment. This initiative aims to make cutting-edge cancer treatments more accessible and support more equitable access to clinical trials across the region.
[From left to right] Mr. Wilson Lai, General Manager of Raffles Medical Indochina and Dr. Nguyen Huu Nguyen, Co-founder and Deputy CEO of Gene Solutions.
Empowering patients with new opportunities
Through this collaboration, patients in Vietnam and Southeast Asia will have improved opportunities to join innovative cancer studies without traditional barriers. From initial genetic testing and eligibility screening to ongoing clinical care and assistance, patients and their families will receive guidance to navigate complex treatment journeys with confidence and clarity.
Understanding precision medicine
Modern cancer treatments are moving beyond “one-size-fits-all” approaches. Precision therapies, such as targeted drugs and immunotherapies, work by focusing on specific genetic changes or immune pathways that drive cancer growth. While many targeted therapies are already approved, there are still numerous genes and mutations without effective drugs. This is why more clinical trials are essential to evaluate new treatments and bring more hope to patients.
As Gene Solutions’ signature oncology test, K-4CARE, states in its tagline: “Unveiling details, unlocking hope”—the more we understand about a tumor’s DNA and RNA profile, the greater the chance patients have of accessing approved drugs or joining global clinical trials. To identify these opportunities, doctors need to look deep into the tumor’s genetic code. This is where Next Generation Sequencing (NGS) comes in. Gene Solutions uses NGS to decode the cancer’s genetic profile and pinpoint patients who may respond to advanced treatments. Without this testing, many patients would never know they qualify for life-changing clinical trials.
Expert perspective
Professor Yasuo Saijo, Medical Oncologist at Raffles Medical Indochina, shared: “For oncologists, genomic insights are transforming how we approach cancer care. By understanding the tumor’s genetic and transcriptomic profile, we can make more informed decisions, such as selecting the right therapy at the right time, tailoring treatment to each patient’s unique biology, and improving both outcomes and quality of life.”
Raffles’ dedicated Clinical Trials Unit
Raffles Medical Group brings decades of experience in delivering high-quality cancer care and conducting clinical trials. Through its Raffles Cancer Centre and dedicated Clinical Trials Unit, the Group has participated in more than 50 international studies, ensuring patients receive access to promising therapies under the highest standards of safety and ethics. Its multi-disciplinary approach and advanced facilities in Singapore make it a trusted destination for complex cancer care and innovative treatments across Southeast Asia.
First step: KRYSTAL-7
The collaboration will begin with KRYSTAL-7, a global study enrolling participants diagnosed with non-small cell lung cancer (NSCLC) with KRAS G12C mutation who have received no prior treatments. This is the first of many clinical trials planned under the partnership, reflecting a shared commitment to improving patient outcomes through innovation and international cooperation.
“Raffles Medical Group is delighted to partner with Gene Solutions to bring cutting-edge clinical trials to patients in Vietnam and across Southeast Asia. This collaboration reflects our commitment to advancing precision medicine and improving patient outcomes,” says Mr. Wilson Lai, General Manager of Raffles Medical Indochina.
“With one of the largest market shares for comprehensive genomic profiling across Southeast Asia, Gene Solutions can pre-screen a vast pool of patients and identify those who may benefit from clinical trials. By combining this capability with Raffles’ clinical excellence, we can accelerate access to promising new therapies for patients throughout the region,” says Dr. Nguyen Huu Nguyen, Co-founder and Deputy CEO of Gene Solutions.
About Gene Solutions
Gene Solutions is a multinational biotechnology company at the forefront of genetic testing and research innovation across the Asia-Pacific region. Leveraging Next-Generation Sequencing (NGS) and Artificial Intelligence, the company offers a comprehensive portfolio of advanced solutions, including:
- Next-generation non-invasive prenatal testing (NIPT), which covers both fetal abnormalities and maternal health indicators.
- Clinically validated multi-cancer screening using multi-omics circulating tumor DNA (ctDNA) technology for early detection and tumor-of-origin localization.
- Comprehensive genomic and transcriptomic profiling combined with clinically validated ctDNA-based molecular residual disease (MRD) monitoring to guide precision treatment and track disease progression.
With over two million genetic tests delivered since 2017, Gene Solutions is recognized for its proprietary research, CAP-accredited laboratories, and contributions to advancing precision medicine through clinical studies, technology development, and regional collaborations. For more information, please visit genesolutions.com.
About Raffles Medical Group
Founded in 1976, Raffles Medical Group is one of the leading integrated private healthcare providers in the region, providing a continuum of services from primary and tertiary care to health insurance for people across Asia. A proudly Singaporean brand, RMG is listed on the mainboard of the Singapore stock exchange (SGX: BSL) and operates in 14 cities in five countries in Asia. This network includes four hospitals and over 100 multi-disciplinary clinics, offering services such as health screening, specialist care, diagnostic radiology, dental and traditional Chinese medicine. Together with about 2,900 employees, RMG brings over 48 years of trusted healthcare expertise and care to more than 2.8 million patients across our network as their trusted partner for health. For more information, please visit rafflesmedicalgroup.com.
CreatorWeek 2025 Launches in Macao, Offering a Unique, Vibrant Platform for Global Content Creators to Connect, Collaborate, and Innovate
MACAO, Oct. 27, 2025 /PRNewswire/ — CreatorWeek Macao 2025, co-organized by Macao Government Tourism Office (MGTO) and Branded, with Adbeyond Group Macau as a collaborative partner, is currently taking place from October 24 to 28. The event is transforming the city into a vibrant showcase of global creativity. With more than 180 creator groups, 50 keynote speakers, and 20 live acts gathering from around the world, the event is drawing wide attention as Macao’s first large-scale celebration of the creator economy.
The CreatorWeek opening party on October 24 at Wynn Palace set the stage for a week unfolding with creative energy and international dialogue. Participants shared creative insights and explored how diverse stories can be expressed globally through new content formats. The event fostered a vibrant exchange where Chinese creators shared their traditions and modern perspectives, while international creators reinterpreted these narratives for worldwide audiences. Through interactive experiences, attendees highlighted Macao’s creative vitality, and its unique position as a crossroads of East and West.
The CreatorWeek Conference, taking place on October 27-28 at the Grand Lisboa Palace Resort Macau, will unite creators, social media leaders, and representatives from Google, Bilibili, Meta, YouTube, Red, and Douyin. Notable guests such as Stokes Twins and Alan Chikin Chow are joining discuss on East-West community differences, monetization, and cross-cultural collaboration, reinforcing Macao’s role as a creative hub.
Participants are immersed in sessions beyond digital production. Wellness Workshops are underway at MGM’s Fantasy Box, with creators like Will Liu and Matt Tralli leading participants through a series of wellness training sessions, while the Meet and Greet on October 25–26 at The Londoner Macao are drawing hundreds of fans for close-up interactions with 40 popular creators including Apl.de.Ap, Steven He, and Berywam.
Meanwhile, Galaxy Macau™ will take center stage for CreatorWeek Live, featuring performances by international stars such as K-pop group XODIAC, Japan’s Psychic Fever from EXILE TRIBE, and the Philippines’ Mikey Bustos. The CreatorWeek Academy will launch a series of practical workshops, featuring industry experts and leading platform representatives sharing insights on content creation and strategies for expanding into global markets.
A special Local Community Tour pairs international creators with local ambassadors to explore the city’s neighborhoods, cuisine, and culture, creating collaborative content that broadcasts Macao’s spirit to global audiences.
“CreatorWeek Macao 2025 is unveiling Macao’s unique glamour and rich multicultural heritage to the world. By propelling tourism through creativity, the event is injecting fresh energy into Macao’s transformation into a world centre of tourism and leisure,” remarked MGTO Director Maria Helena de Senna Fernandes.
For the latest updates and event livestreams, visit the official website at www.creatorweek.live or follow @visitmacao on Instagram, Facebook, YouTube, TikTok, and Red.
About Macao
Macao is a vibrant city known for its rich cultural heritage, world-class entertainment, and diverse culinary scene. As a premier travel destination, Macao offers a unique blend of East and West, where ancient traditions meet modern attractions.
Laos Signs UN Cybercrime Convention to Boost Digital Security
Laos has formally joined the United Nations Convention against Cybercrime, signaling its commitment to global cooperation in combating cyber threats and advancing its digital transformation agenda.
AIA Hong Kong leads in “number of new business policies” for 11 consecutive years
HONG KONG SAR – Media OutReach Newswire – 27 October 2025 – AIA Hong Kong (AIA) has once again led across key market metrics in the latest provisional statistics on Hong Kong’s long-term insurance business for the first half of 2025*. Notably, AIA has retained its No.1 position in number of new business policies for 11 consecutive years**— a clear reflection of customers’ enduring trust.
AIA Hong Kong together with Blue Cross were honoured with the highest number of Top-3 Finalist Awards — winning a total of 12 accolades, including 3 Grand Awards. Pictured here is Mr. Alger Fung, Chief Executive Officer of AIA Hong Kong & Macau.
Mr. Alger Fung, Chief Executive Officer of AIA Hong Kong & Macau, said, “Thanks to our customers’ trust, AIA has led in number of new business policies for 11 consecutive years. This leadership means that when people seek protection for their future and loved ones, AIA remains their top choice because our health and wealth solutions, along with services beyond traditional insurance, truly stand out. What matters most to AIA is helping every customer prepare for the future and care for their loved ones, moving forward with confidence towards Healthier, Longer, Better Lives, while serving diverse customer needs across different coverage sizes. With the trust customers places in us, AIA will continue serving our customers and communities with unwavering commitment to helping people live Healthier, Longer, Better Lives.”
Meanwhile, at the award ceremony of the Hong Kong Insurance Awards 2025 organised by The Hong Kong Federation of Insurers on the evening of 23 October, AIA together with Blue Cross were honoured with the highest number of Top-3 Finalist Awards — winning a total of 12 accolades, including 3 Grand Awards.
| AIA | 3 Grand Awards:
7 Top-3 Finalist Recognitions:
|
| Blue Cross | 2 Top-3 Finalist Recognitions:
|
Notes:
* Source: The latest provisional statistics of the Insurance Authority on Hong Kong long-term insurance business from January to June 2025.
** Based on statistics from Insurance Authority released since 2014 – Provisional statistics of the Insurance Authority on Hong Kong long-term insurance business.
Hashtag: #友邦香港 #AIA
The issuer is solely responsible for the content of this announcement.
About AIA Hong Kong & Macau
AIA Group Limited established its operations in Hong Kong in 1931. To date, AIA Hong Kong and AIA Macau have about 18,000 financial planners1, as well as an extensive network of independent financial advisors, brokerage and bancassurance partners. We serve over 3.6 million customers2, offering them a wide selection of professional services and products ranging from individual life, group life, accident, medical and health, pension, personal lines insurance to investment-linked assurance schemes with numerous investment options. We are also dedicated to providing superb product solutions to meet the financial needs of high-net-worth customers.
1 As at 30 June 2025
2 Including AIA Hong Kong and AIA Macau’s individual life, group insurance, and pension customers (as at 30 June 2025)
ADDX Partners with Global Real Estate Investment Manager Hines to Broaden Access to Quality Real Estate Opportunities
SINGAPORE, Oct. 27, 2025 /PRNewswire/ — ADDX today announced a partnership with Hines, a leading global real estate investment manager. The collaboration brings together Hines’ experience in investing in, developing, and managing some of the world’s best real estate with ADDX’s digital platform, uniting investment management excellence with modern financial infrastructure to broaden access and expand opportunities in private markets.
The partnership comes at a time when the private real estate market is supported by secular tailwinds. Structural themes such as urbanisation, demographic shifts, and the rising demand for modern logistics, data centres, and sustainable living solutions continue to underpin the asset class. Private real estate offers investors both the potential for long-term capital appreciation through asset value growth and consistent income generation from underlying leases.
According to research by Hines, historical data reinforces a strong correlation between global property rents and inflation. A strategic allocation to geographically diversified global real estate assets could provide portfolios with the potential for capital appreciation, inflation hedging, income distributions, and downside risk mitigation resulting from a lower level of volatility.
Amid a period of recalibration following years of higher interest rates, experienced operator-led managers like Hines are well positioned to navigate these dynamics and identify opportunities grounded in enduring real economic value.
“Partnering with a time-tested manager like Hines reinforces our focus on working with firms that share our dedication to disciplined investing and responsible access to private markets,” said Inmoo Hwang, Group Managing Director and Chief Financial Officer of ADDX. “Hines embodies the calibre of real estate expertise and disciplined management that aligns with our commitment to offering investors access to quality partners.”
Founded in 1957, Hines manages more than USD 90 billion in assets globally and is recognised for its vertically integrated, operator-led model, combining on-the-ground execution with disciplined investment management across property types and geographies.
“Asia is a key growth region for our private wealth business, and we’re excited to expand Hines’ investment opportunities here, giving individual investors access to institutional-quality global real estate,” said Paul Ferraro, Global Head of Private Wealth at Hines. “Building on Hines’ extensive experience in the U.S. private wealth market, we’re strategically broadening our platform to serve investors across global markets. As demand from Asian investors for greater diversification continues to grow, platforms like ADDX help us connect with this dynamic base and make global real estate more accessible.”
The partnership reflects ADDX’s broader mission to democratise participation in private markets through regulated technology, while upholding a strong commitment to quality. By working with established global institutions such as Hines, ADDX continues to expand its ecosystem of trusted partners and shelf of alternative investment opportunities.
About ADDX
ADDX is an investment platform headquartered in Singapore that provides accredited investors with access to private markets, alternatives, and differentiated opportunities to help them diversify and grow their wealth, all at lower minimums. With ADDX, investors can access high-quality investments across private equity, private credit, private real estate, hedge funds, structured products, cash alternatives, fixed income, and more, using a convenient and user-friendly app and web platform. The platform uses digital securities and tokenisation technology to fractionalise investments, making traditionally institutional-grade opportunities more accessible.
ADDX has raised a total of US$140 million in funding since its inception in 2017. Its shareholders include Singapore Exchange (SGX), the Stock Exchange of Thailand, Temasek subsidiary Heliconia Capital, the Development Bank of Japan, UOB, Hamilton Lane, Tokai Tokyo Financial Holdings and KB Securities, a subsidiary of Korea’s largest banking group KB Financial Group.
ADDX has been approved by the Monetary Authority of Singapore as a recognised market operator. It also has a capital markets services license to deal in securities and collective investment schemes as well as to provide custodial services. ADDX serves accredited investors from more than 50 countries spanning Asia Pacific, Europe, the Middle East and the Americas (except the US), alongside wealth managers, family offices and corporate investors. For more information, visit ADDX.co or https://www.linkedin.com/company/addxco.
About Hines
Hines is a leading global real estate investment manager. It owns and operates $91.8 billion[1] of assets across property types and on behalf of a diverse group of institutional and private wealth clients. Every day, its 4,600 employees in 30 countries draw on its 68-year history to build the world forward by investing in, developing, and managing some of the world’s best real estate. To learn more, visit www.hines.com and follow @Hines on social media.
[1]Includes both the global Hines organization and RIA AUM as of June 30, 2025.
|
This press release is for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy any securities or investment products. Investments in private market strategies involve risk and are not suitable for all investors. Offerings on the ADDX platform are available only to accredited investors, as defined under applicable laws and regulations in relevant jurisdictions. Past performance is not indicative of future results. Investors should conduct their own due diligence or consult with a professional adviser before making any investment decisions. |
KLN Named Exclusive Distributor for Siemens Healthineers
Point-of-Care Testing Solutions in Hong Kong
HONG KONG, Oct. 27, 2025 /PRNewswire/ — KLN Logistics Group Limited (‘KLN’; Stock Code 0636.HK) announces a strategic partnership between its healthcare subsidiary, KLN Medical Limited (‘KLN Medical’), and global medical technology leader Siemens Healthineers AG (Stock Code SHL.DE). KLN Medical will serve as the exclusive distributor for Siemens Healthineers’ Point-of-Care Testing products in Hong Kong.
This partnership marks a major milestone for KLN Medical as it expands in life sciences sector. KLN Medical will provide end-to-end agency and distribution services for Siemens Healthineers’ diagnostic portfolio, with a strong focus on professional sales and marketing outreach to hospitals and healthcare providers. Its in-house engineering team will deliver maintenance and repair services to ensure optimal device performance and minimise service disruptions. These capabilities are supported by GDP-compliant logistics, warehousing, and inventory management that uphold the highest standards of medical supply chain excellence.
KLN Medical will distribute these solutions across major hospitals, laboratories, clinics, rehabilitation outlets, and healthcare providers throughout Hong Kong, ensuring Siemens Healthineers’ technologies are accessible and fully supported throughout their lifecycle to maximise clinical value and reliability.
Samuel Lau, Managing Director – Integrated Logistics of KLN, said, “We are honoured to collaborate with Siemens Healthineers, a global leader in diagnostic innovation. This partnership reflects KLN’s commitment to resilient, patient-centric care by ensuring timely access to reliable diagnostics and full-spectrum support.”
In addition to logistics and technical services, KLN Medical will support local marketing, product training, and clinical outreach to enhance engagement with frontline healthcare providers.
Mike Yuen, Head of Hong Kong of Siemens Healthineers, said, “KLN Medical’s strengths in commercial and technical support make them an ideal partner for our expansion in Hong Kong. Together, we will ensure our innovations reach patients and clinicians with excellence and efficiency.”
Siemens Healthineers’ diagnostic solutions are widely used across Hong Kong’s healthcare system, particularly in operating theatres, ICUs, emergency departments, and cardiology units. For example, Queen Mary Hospital’s nationally certified Chest Pain Centre uses Siemens Healthineers’ systems to reduce time-to-treatment for acute chest pain, demonstrating the clinical impact of rapid diagnostics.
This collaboration reinforces KLN Medical’s role as a key enabler in Hong Kong’s medical diagnostics landscape and supports its long-term vision of a more efficient, responsive, and patient-centric healthcare system.
-End-
About KLN Logistics Group Limited (Stock Code 0636.HK)
KLN (formerly Kerry Logistics Network Limited) is an Asia-based, global 3PL with a highly diversified business portfolio and extensive coverage in Asia. It offers a broad range of supply chain solutions from integrated logistics, international freight forwarding (air, ocean, road, rail and multimodal) and e-commerce to industrial project logistics and infrastructure investment.
With a global presence across 58 countries and territories, KLN has established a solid foothold in half of the world’s emerging markets. Its diverse infrastructure, extensive coverage in international gateways and local expertise span across the Chinese Mainland, India, Southeast Asia, the CIS, Middle East, LATAM and other locations.
KLN generated a revenue* of close to HK$60 billion in 2024. It is listed on the Hong Kong Stock Exchange and is a constituent of the Hang Seng Corporate Sustainability Benchmark Index.
* For continuing operations only
About KLN Medical Limited
KLN Medical is dedicated to advancing healthcare in Hong Kong and Southeast Asia by delivering innovative medical technologies that improve patient outcomes. In collaboration with world-renowned partners, KLN Medical ensures that healthcare professionals have access to the latest advancements, driving excellence across the continuum of care. As a member of the KLN Group, KLN Medical focuses on the reliable distribution of high-quality medical devices and solutions. Its multidisciplinary team brings deep expertise across key areas including cardiovascular care, rehabilitation, hospital and clinic support, engineering, marketing, business development, regulatory affairs and quality assurance, customer service, and operations. Website: www.medical.kln.com
About Siemens Healthineers AG
Siemens Healthineers pioneers breakthroughs in healthcare. For everyone. Everywhere. Sustainably. The company is a global provider of healthcare equipment, solutions and services, with activities in more than 180 countries and direct representation in more than 70. The group comprises Siemens Healthineers AG, listed as SHL in Frankfurt, Germany, and its subsidiaries. As a leading medical technology company, Siemens Healthineers is committed to improving access to healthcare for underserved communities worldwide and is striving to overcome the most threatening diseases. The company is principally active in the areas of imaging, diagnostics, cancer care and minimally invasive therapies, augmented by digital technology and artificial intelligence. In fiscal 2024, which ended on 30 September 2024, Siemens Healthineers had approximately 72,000 employees worldwide and generated revenue of around €22.4 billion. Further information is available at www.siemens-healthineers.com
